FDA Inspection 1090370 — Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
The FDA completed an inspection of Octapharma Pharmazeutika Produktionsgesellschaft m.b.H. on April 16, 2019 in Vienna. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 16, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Vienna (Austria)